Navigation Links
Prosum Kicks Off Crowd Funding for Cancer Research
Date:8/9/2012

RENO, Nev., Aug. 9, 2012 /PRNewswire/ -- Prosum Breast Cancer Research, Inc. announces a Crowd Funding financing project to jump start its first research project to build the "You Will Be the Cure" for early detection breast health awareness and research. "Our first awareness project focuses on communicating individual experiences of women to educate all about the value with early detection starting at age 20," says Dave Wertzberger, Executive Director.

"We believe early detection education is much more than statistics and technology—women are the cure. The collective experience of survivors needs to be shared. We are convinced the profiles of women who have 'been there and done that' will provide invaluable awareness for women of all ages to advance the cure starting with early detection," adds Cindy Lain, Community Affairs Director.  "In addition, we see a number of early detection technologies coming to market and our goal is to confidentially involve volunteers with these technologies to improve device early detection usability and value," continues Wertzberger.

"Our Crowd Funding site at Rockethub.com provides one location to describe project goals and how individuals can support a new level of information for improving early detection and survival," says Wertzberger. "The Crowd Funding approach simplifies fund raising with contributions of $10, or more, while engaging folks wherever there is an Internet connection," says Wertzberger.

Prosum's awareness project will collect video histories as well as personal profiles in preparation for an updated web site for those who wish to share their stories to be part of our "You Will Be the Cure" awareness and research on early detection.  The fund raising goal is $30,000.  Any additional funds will be used to develop a confidential Breast Cancer History Database to improve early detection devices for positive change.

Press Ctrl, Click to follow the link Prosum Rocket Hub Link

About Prosum Breast Cancer Research

Prosum Research Foundation, Inc., dba Prosum Breast Cancer Research, (PBCR) is based in Reno, NV.  Founded in 2008, PBCR is a non-profit foundation dedicated to the dissemination of breast health information and education while advancing the state-of-the art of early detection of breast cancer to enhance current detection technologies to delivery early screening to more women by any physician.  www.prosumresearch.org 

For more information, contact: Dave Wertzberger, Executive Director 800-448-4981 dwertzberger@prosumresearch.org


'/>"/>
SOURCE Prosum Breast Cancer Research, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmatech Oncology Receives Phase 2 SBIR Funding for Just-In-Time Enrollment Model
2. RD Legal Funding Provides Immediate Settlement Financing to Growing Number of Yaz and Yasmin Plaintiffs
3. DePuy & Transvaginal Mesh Lawsuit Settlement Funding Leads Legal-Bay to Banner 2nd Quarter
4. BONESUPPORT Closes Second Tranche of Funding
5. Elsevier and Russias Skolkovo Foundation Sign Access Agreement to SciVerse Scopus and SciVal Funding
6. Igenica Closes $33 Million in Series C Funding
7. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
8. Xtelligent Media Raises $800K in Funding and Launches EHRintelligence.com
9. Independa Closes Convertible Note Funding at $2.35 Million
10. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
11. OncoGenex Announces Initiation of the Phase 3 "AFFINITY" Trial for Patients with Advanced Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/8/2017)... Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused on ... the second quarter ended June 30, 2017. ... to date: Continued ... lead project, BL-8040: Announced plans to ... stem cell mobilization treatment for autologous bone-marrow transplantation in ...
(Date:8/7/2017)... Ind. , Aug. 7, 2017 Zimmer Biomet ... musculoskeletal healthcare, today announced that its Board of Directors has ... for the third quarter of 2017. ... be paid on or about October 27, 2017 to stockholders ... 22, 2017.  Future declarations of dividends are subject to approval ...
(Date:8/7/2017)... International plc (NASDAQ: ENDP ) today announced that ... U.S. mesh product liability claims and that it is ... claims at reasonable values. Under the agreements, Endo will ... 2017 and continuing through the fourth quarter of 2019. ... Company intends to increase its mesh product liability accrual ...
Breaking Medicine Technology:
(Date:8/22/2017)... ... ... The Women’s Choice Award, a growing platform that gives a voice to ... Award. The identification by women of an effective new migraine relief product ... In a survey taken by the Women’s Choice Award organization, nine out of ten ...
(Date:8/22/2017)... ... August 22, 2017 , ... Western North Carolina’s only ... popular international aesthetics conference for medical professionals about the positive impact Juliet™ ... his growing practice. , Dr. George K. Ibrahim shared the results ...
(Date:8/22/2017)... ... ... six years, Lightning Labels has sent out a call for users of its custom label ... of their designs. Submissions this year were open from May 18 to July 1 and ... of the sixth annual Photo Contest, along with the prizes they've received:, ...
(Date:8/22/2017)... ... 2017 , ... Nurses at Apple Rehab Watch Hill , a nursing ... and certification in Closed Pulse Irrigation™ (CPI) for wound care. This qualifies ... Centers for Medicare and Medicaid Services, to have a CPI machine that will provide ...
(Date:8/22/2017)... (PRWEB) , ... August 22, 2017 , ... “To Walk ... radioman on a B17 bomber named Edward Koontz. “To Walk Away” is the creation ... Scranton, who has published over two hundred manuscripts in chemistry and religion, as well ...
Breaking Medicine News(10 mins):